Thrombus, embolism and stroke

Is administered to dissolve blood clot in case of stroke.

Reduces risk of thrombosis.

Prevents cAMP breakdown in platelets, keeping platelets from aggregating.

Known side effects include rhabdomyolysis and acute renal failure.

Is an anti-platelet drug

Inhibits thrombus formation.

Dissolves emboli

Must be administered within 60 minutes of a stroke to be effective.

Inhibits glycoprotein IIb/IIIa receptor expression on platelets by blocking the ADP receptor irreversibly